{"name":"Andres J. M. Ferreri","slug":"andres-j-m-ferreri","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BEAM conditioning","genericName":"BEAM conditioning","slug":"beam-conditioning","indication":"Other","status":"phase_2"},{"name":"Intensification phase","genericName":"Intensification phase","slug":"intensification-phase","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BEAM conditioning","genericName":"BEAM conditioning","slug":"beam-conditioning","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intensification phase","genericName":"Intensification phase","slug":"intensification-phase","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9aUWtKTnNRRFo1ZEVlWTdYNVl6bFpqR3djcVB5Rlg5XzJPcFlkb3ZDZ2NKUFBPb2pmVWtCVkhJNmdqb0ZNQ1lqcGVmbHZkTnNDdU02b2E0WG5rMExTNUNfd29MVDJjVzg?oc=5","date":"2024-06-04","type":"pipeline","source":"Wiley Online Library","summary":"Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - Wiley Online Library","headline":"Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}